Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: Comparison of T-cell lymphoma with and without hemophagocytic syndrome

Leukemia and Lymphoma

Volumn 49, Issue 1, 2008, Pages 81-87

  Tong, Hongyan ^a,b   Ren, Yanling ^a,b   Liu, Hui ^a,b   Xiao, Feng ^a,b   Mai, Wenyuan ^a,b   Meng, Haitao ^a,b   Qian, Wenbin ^a,b   Huang, Jian ^a,b   Mao, Lingping ^a,b   Tong, Ying ^a,b   Wang, Lei ^a,b   Qian, Jiejing ^a,b   Jin, Jie ^a,b,c  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Lymphoma associated hemophagocytic syndrome (LAHS); Plasmapheresis; Survival; T cell lymphoma

Indexed keywords

ASPARAGINASE; BETA 2 MICROGLOBULIN; CA 125 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FERRITIN; FIBRINOGEN; IDARUBICIN; IFOSFAMIDE; LACTATE DEHYDROGENASE; MITOXANTRONE; PREDNISOLONE; PREDNISONE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIA; BONE MARROW BIOPSY; BONE MARROW DISEASE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPENIA; DISEASE CLASSIFICATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; EARLY INTERVENTION; FEMALE; FERRITIN BLOOD LEVEL; FEVER; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; LIVER DYSFUNCTION; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PERIPHERAL T CELL LYMPHOMA; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL TIME; T CELL LYMPHOMA; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW EXAMINATION; FEMALE; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 38549096546     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701713630     Document Type: Article

References (23)

1. Risdall, R. J., McKenna, R. W., Nesbit, M. E., Krivit, W., Balfour Jr, H. H. and Simmons, R. L. (1979) Virus associated hemophagocytic syndrome: A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer, 44, pp. 993-1002.
2. Cheng, A. L., Su, I. J., Chen, Y. C., Uen, W. C. and Wang, C. H. (1993) Characteristic clinicopathologic features of Epstein-Barr virus associated peripheral T-cell lymphoma. Cancer, 72, pp. 909-916.
3. Cheung, M. M., Chan, J. K., Lau, W. H., Foo, W., Chan, P. T. and Ng, C. S. (1998) Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol, 16, pp. 70-77.
4. Linn, Y. C., Tien, S. L., Lim, L. C., Lee, L. H., Teoh, G. and Goh, Y. T. (1995) Haemophagocytosis in bone marrow aspirate: A review of the clinical course of 10 cases. Acta Haematol, 94, pp. 182-191.
5. Takahashi, N., Miura, I., Chubachi, A., Miura, A. B. and Nakamura, S. (2001) A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma. Int J Hematol, 74, pp. 303-308.
6. Gutierrez, A., Solano, C., Ferrandez, A., Marugan, I., Terol, M. J. and Benet, I. (2003) Peripheral T-cell lymphoma associated consecutively with hemophagocytic lymphohistiocytosis and hypereosinophilic syndrome. Eur J Haematol, 71, pp. 303-306.
7. Rudiger, T., Weisenburger, D. D., Anderson, J. R., Armitage, J. O., Diebold, J. and MacLennan, K. A. (2002) Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): Results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol, 13, pp. 140-149.
8. The Non-Hodgkin's Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma. Blood, 89, pp. 3909-3918.
9. Ascani, S., Zinzani, P. L., Gherlinzoni, F., Sabattini, E., Briskomatis, A. and de Vivo, A. (1997) Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. classification. Ann Oncol, 8, pp. 583-592.
10. (1993) A predictive model for aggressive non-Hodgkin's lymphoma: The International NHL Prognostic Factors Project. N Engl J Med, 329, pp. 987-994.
11. Janka, G. E. and Schneider, E. M. (2004) Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol, 124, pp. 4-14.
12. Takahashi, N., Chubachi, A., Miura, I., Nakamura, S. and Miura, A. B. (1999) Lymphoma associated hemophagocytic syndrome in Japan. Rinsho Ketsueki, 40, pp. 542-549.
13. Shimazaki, C., Inaba, T., Okano, A., Hatsuse, M., Takahashi, R. and Hirai, H. (2001) Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): Comparison of CD5+ with CD5-B-LAHS. Intern Med, 40, pp. 878-882.
14. Stein, H., Mason, D. Y., Gerdes, J., O'Connor, N., Wainscoat, J. and Pallesen, G. (1985) The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood, 66, p. 848.
15. Tilly, H., Gaulard, P., Lepage, E., Dumontet, C., Diebold, J. and Plantier, I. (1997) Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood, 90, p. 3727.
16. Gascoyne, R. D., Aoun, P., Wu, D., Chhanabhai, M., Skinnider, B. F. and Greiner, T. C. (1999) Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood, 93, pp. 3913-3921.
17. Belhadj, K., Reyes, F., Farcet, J. P., Tilly, H., Bastard, C. and Angonin, R. (2003) Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: Report on a series of 21 patients. Blood, 102, pp. 4261-4269.
18. Zidan, J., Hussein, O., Basher, W. and Zohar, S. (2004) Serum CA125: A tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphoma. Oncologist, 9, pp. 417-421.
19. Zacharos, I. D., Efstathiou, S. P., Petreli, E., Georgiou, G., Tsioulos, D. I. and Mastorantonakis, S. E. (2002) The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma. J Haematol, 69, pp. 221-226.
20. Tsuda, H. (1997) Hemophagocytic syndrome (HPS) in children and adults. Int J Hematol, 65, pp. 215-226.
21. Sanada, S., Ookawara, S., Shindo, T., Morino, K., Ishikawa, H. and Suzuki, M. (2004) A case report of the effect of plasma exchange on reactive hemophagocytic syndrome associated with toxic shock syndrome. Ther Apher Dial, 8, pp. 503-506.
22. Coman, T., Dalloz, M. A., Coolen, N., Heshmati, F., Pene, F. and Cariou, A. (2003) Plasmapheresis for the treatment of acute pancreatitis induced by hemophagocytic syndrome related to hypertriglyceridemia. J Clin Apher, 18, pp. 129-131.
23. Yanagiya, N., Takahashi, N., Nakae, H., Kume, M., Chubachi, A. and Miura, I. (2002) Plasma exchange and continuous hemodiafiltration as an initial treatment for diffuse large B-cell lymphoma-associated hemophagocytic syndrome. Rinsho Ketsueki, 43, pp. 35-40.